Tanveer Naseer

MARCH 10, 2015

The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. But that’s not the way radical innovators envisage their organizations. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

Marshall Goldsmith

FEBRUARY 24, 2014

Every company wants “integrity,” “respect for people,” “quality,” “customer satisfaction,” “innovation,” and “return for shareholders.” What Got You Here Won’t Get You There has been listed as the #2 bestselling business book for 2012 by INC magazine / 800 CEO Read.

Ethics 137

Ethics Pharmaceuticals PR Execution 137

Strategy Driven

DECEMBER 13, 2018

A few years back, I coached a national pharmaceutical team with distinct geographies. Gerber is Founder and CEO of Focus One, a consulting firm that helps leaders create High Performance Teams. Drawing from his own extensive background and 10 years of research, Douglas innovated the concept of “Team Quotient” (TQ).

Team 58

Team Pharmaceuticals Project Learning-by-Doing 58

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

OCTOBER 7, 2014

It can certainly be valuable to have the help of strategy officers or teams on refining and implementing strategy, but the strategy itself needs to be conceived and owned by the CEO (or equivalent for a division). It follows that the CEO must deeply understand customer needs and how to meet them.

CEO 11

CEO Strategy Pharmaceuticals B2B 11

Harvard Business Review

NOVEMBER 27, 2013

When is the best time for a CEO to leave the top spot? A similar problem plagues corporate CEOs: usually, they don’t leave until they’re forced out. Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry.

CEO 13

CEO Long-term Welch Pharmaceuticals 13

Harvard Business Review

DECEMBER 14, 2015

It’s no surprise, then, that the popularity of meditation – one way to practice mindfulness – is also growing among CEOs and senior executives. Because there’s something to meditation that appears to benefit CEOs more than recreation or relaxation do alone. Doty, an early investor, became the CEO.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Ethics Productivity 140

Coaching Tip

MARCH 15, 2011

All it takes is the desire to be innovative and creative in tackling a problem. Al Weatherhead is the author of The Power Of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

SEPTEMBER 26, 2011

In the past 25 years, CEOs of many major corporations have relied on a flawed set of beliefs to lead their organizations. This environment and the behavior produced by the prevailing set of beliefs to which CEOs subscribe have deepened a widespread public distrust of corporations and capitalism. The Conventional Wisdom.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). New technologies, combined with business model innovation, provide the structural cost advantage necessary to take large chunks of the market over time.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

MARCH 9, 2015

Savvy CEOs use fire to fight fire, effectively employing digital media inside their organizations to create the kind of alignment and shared purpose they need. This allows CEO Satya Nadella to hear early warning signals. For example, a study of a multinational pharmaceutical company revealed that leaders in its U.S.

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

DECEMBER 27, 2016

The CEOs of both — John Noseworthy and Delos “Toby” Cosgrove — are highly skilled physicians. A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. Cleveland Clinic comes in second.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

JULY 7, 2016

” Howard Schultz, the chair, president, and CEO of Starbucks revealed that he, and CEOs he knows, feel the same way : “Very few people, whether you’ve been in that job before or not, get into the seat and believe today that they are now qualified to be the CEO. This is true in business as well. And it works!

How To 14

How To Pharmaceuticals Learning-by-Doing Tips 14

Harvard Business Review

MARCH 2, 2012

As a consequence, five of its CEOs have been non-American-born, including today's CEO, Turkish-born Muhtar Kent. Many global companies have followed Coke's lead by appointing foreign-born CEOs and executives. UK-born George Buckley, CEO of 3M, will be succeeded by Swedish-born Inge Thulin.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

JULY 14, 2017

A recent survey on easing racial tensions at work by the Center for Talent Innovation found that “The workplace is one of few settings where we commonly interact across racial and ethnic lines.” And a growing number of CEOs and chairs are taking positions on political and social issues. and worldwide.

Diversity 9

Diversity Politics Survey Incubator 9

Harvard Business Review

JANUARY 24, 2012

I'll be joined by five CEOs, among them George Halvorson , who heads the health care provider Kaiser Permanente, Vincent Forlenza who runs Becton Dickinson, the pharmaceutical company, and Tim Brown , the CEO of IDEO, the design and innovation firm. on Friday night.

Meyer 14

Meyer Goleman Emotional Intelligence Pharmaceuticals 14

Harvard Business Review

FEBRUARY 4, 2013

Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Business would change the rules of the game. Breakthrough Science. Breakthrough Institutions.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

JANUARY 8, 2013

Breaking down functional silos is key to everything from encouraging communication to building valuable connections to sparking innovation. arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). Among the first 100 participants: BIPI's CEO, who was matched with a young member of one of the brand marketing teams. "A

Company 9

Company Pharmaceuticals Health Care Participative 9

Harvard Business Review

SEPTEMBER 13, 2012

Managers and business analysts will often be called upon to conduct data-driven experiments, to interpret data, and to create innovative data-based products and services. Procter & Gamble's CEO, Bob McDonald, is convinced that "data modeling, simulation, and other digital tools are reshaping how we innovate."

Skills 17

Skills Pharmaceuticals Sample Business Intelligence 17

Harvard Business Review

JANUARY 10, 2014

By one insider’s account, recent mergers among big pharmaceutical firms led to R&D cutbacks and reduced productivity. Interest in “innovation,” on the other hand, has risen more strongly and continues unabated. Big mergers may help cut costs, but more nuanced strategies are needed to drive innovation.

Restructuring 8

Restructuring Trends Long-term Short-term 8

Harvard Business Review

AUGUST 14, 2018

ineffective innovation strategies. 5 Principles for Innovation in Emerging Markets. They operate in an environment where the barriers to entry are relatively low and the focus of competition is on product and business model innovations and service delivery, rather than the most advanced technologies. Related Video.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 8, 2013

Over the past 20 years, no group has endured greater pain and humiliation within organizations than mid-level managers (MLMs — managers from two levels below the CEO down to the line managers). Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 8

Middle Management Management Automotive Pharmaceuticals 8

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

FEBRUARY 6, 2014

In one of the most widely scrutinized CEO successions ever, Microsoft directors selected insider Satya Nadella to run the company, only their third CEO pick in the firm’s nearly 40-year history. Even the sitting CEO who knew the three finalists as well as anybody was surprised. His challenges will be enormous.

CEO 8

CEO Bottom-up Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 5, 2016

Its CEO, John Fallon, says of this approach, “It is by having a bigger impact on education — measured by expanding access and improving outcomes — that we will make Pearson a faster-growing and more sustainably profitable company.” There is enough time to develop innovative solutions to achieve the results.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. Although its readership was at historic highs, the CEO was determined to double its subscription base over the next five years. paul Garbett for HBR. In five years, the revenue shortfall would be significant.

Leadership 10

Leadership Diversity Committee Long-term 10

Harvard Business Review

OCTOBER 26, 2011

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Their behavior displays promising parallels to the early days of the biotechnology industry. Click on the table below to see at full size.).

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. This work builds on earlier research into CEO qualifications.).

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JANUARY 30, 2014

Its wellness lobbying campaign — largely urging Congress to allow employers to designate more health care spending for behavior modification — is led by a CEO in the casino industry who exposes his employees to more second-hand smoke than virtually any CEO in the country. The distinction should be self-evident.

Human Resources 10

Human Resources Guidelines Morale Insurance 10

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. “Japanese leaders recognize the importance of encouraging medical innovation,” Eli Lilly and Co. chairman and CEO David A.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8

Harvard Business Review

MAY 18, 2015

For example, Jamie Dimon, CEO of JP Morgan, said that since 2012 his bank hired an additional 13,000 people to work in the area of compliance. This hard-wired tendency was nicely demonstrated by the CEO of Apple, Tim Cook, when reacting to the allegations that Apple engages in actions of tax avoidance.

Compliance 8

Compliance Company Self-aware Ethics 8

Harvard Business Review

MAY 16, 2011

Scott McNealy , ex-CEO of Sun Microsystems, tweeted this message last month : "Most over used phrase in business is 'strategic partner.' Most major pharmaceutical companies are well-known for their joint R&D deals with biotech start-ups. Favorite partnership for me is a purchase order. Defined charter, beginning, end.".

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

SEPTEMBER 5, 2013

In 2011, Thierry Andretta, the CEO of French fashion company Lanvin, announced an initiative called "no email Wednesdays" because he thought people had stopped actually talking to each other. Marissa Mayer, Yahoo''s CEO, ended the company''s work-from-home policy to foster a more collaborative, innovative environment.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

MAY 7, 2015

If you’re Amazon, Disney, some of the pharmaceuticals…the markets support their huge long-term investments because they can see where the investments will lead. If you go back to BP and consider then-CEO John Browne – he did an extraordinary job building that company. It can be done. But he was an exploration guy.

Short-term 8

Short-term Henderson Long-term Metrics 8

Harvard Business Review

OCTOBER 11, 2013

Four years ago, Craig Hatkoff, co-founder of the Tribeca Film Festival, approached me about a brainstorm: an event recognizing and celebrating breakthrough innovators. When I suggested to Clayton Christensen that we partner with Hatkoff to create the Tribeca Disruptive Innovation Awards , Clay’s response was : I trust you Whitney.

Innovation 11

Innovation Christensen Decisionmaking CTO 11